Paloma Partners’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,151
| Closed | -$209K | – | 938 |
|
|
2024
Q1 | $209K | Buy |
+7,151
| New | +$209K | 0.01% | 361 |
|
|
2020
Q4 | – | Sell |
-4,512
| Closed | -$271K | – | 1822 |
|
|
2020
Q3 | $271K | Buy |
4,512
+324
| +8% | +$19.5K | 0.01% | 1395 |
|
|
2020
Q2 | $220K | Buy |
+4,188
| New | +$220K | ﹤0.01% | 1484 |
|
|
2019
Q2 | – | Sell |
-5,752
| Closed | -$219K | – | 1723 |
|
|
2019
Q1 | $219K | Buy |
+5,752
| New | +$219K | 0.01% | 1145 |
|
|
2018
Q1 | – | Sell |
-9,903
| Closed | -$452K | – | 1563 |
|
|
2017
Q4 | $452K | Buy |
+9,903
| New | +$452K | 0.01% | 807 |
|
|
2017
Q1 | – | Sell |
-8,023
| Closed | -$259K | – | 1628 |
|
|
2016
Q4 | $259K | Buy |
+8,023
| New | +$259K | ﹤0.01% | 1300 |
|
|
2016
Q3 | – | Sell |
-13,944
| Closed | -$470K | – | 1562 |
|
|
2016
Q2 | $470K | Buy |
+13,944
| New | +$470K | 0.01% | 1136 |
|